Maine LD697 directs the Maine Prescription Drug Affordability Board to assess strategies to reduce prescription drug costs and implement.
Maine LD697 amends the laws governing the Maine Prescription Drug Affordability Board. It tasks the board with assessing strategies to reduce prescription drug costs, including implementing reference-based pricing. The board must review experiences of other states, consider prescription drug spending data, and solicit public input. The board is also directed to recommend a program to reduce the impact of prescription drug costs on the State's health care system, stem the rate of growth in prescription drug spending, and reduce cost barriers for consumers.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.